ArticleBiomolecules2026

Screening and Engineering of Hetero-Bivalent Nanobody Targeting Interleukin-33 with Enhanced Binding Stability.

Yingxin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.